Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Is It Wise To Hold Ventas (VTR) In Your Portfolio Now?

Published 09/05/2016, 07:58 AM
Updated 07/09/2023, 06:31 AM

We have updated our research report on Ventas, Inc. (NYSE:VTR) on Sep 2, 2016.

Just a couple of days ago, the Chicago, IL-based real estate investment trust (“REIT”) closed the acquisition of significantly all of the life science and medical real estate assets of Wexford Science & Technology, LLC. from the affiliates of Blackstone (NYSE:BX) Group LP for $1.5 billion. The transaction is expected to be accretive to the company’s normalized funds from operations (“FFO”) immediately. Also, this buyout marks the company’s foray into the thriving university-affiliated life science real estate business. It offers a solid diversification to the company.

Earlier on Jul 29, 2016, Ventas reported second-quarter 2016, normalized FFO of $1.04 per share, in-line with the Zacks Consensus Estimate.

Ventas is mainly engaged in the acquisition and ownership of seniors housing and healthcare properties, and leasing them to unaffiliated tenants or operating them through independent third-party managers. The company’s diverse healthcare portfolio with all types of facilities allows it to capitalize on opportunities in different markets based on individual market dynamics. Further, the growing senior citizen population, triple net lease agreements and strong balance sheet augur well for it.

However, a substantial portion of Ventas’ revenues is generated from a few tenants, which raises concentration risks. Further, stiff competition and any rise in interest rates are concerns before it.

For Ventas, the Zacks Consensus Estimate for 2016 and 2017 remained stable at $4.12 and $4.32, respectively, over the past seven days.

Currently, Ventas carries a Zacks Rank #3 (Hold).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Investors interested in the REIT sector can consider some better-ranked stocks like Alexandria Real Estate Equities, Inc. (NYSE:ARE) , Arbor Realty Trust Inc. (NYSE:ABR) and CareTrust REIT, Inc. (NASDAQ:CTRE) . All these stocks hold a Zacks Rank #2 (Buy).

Note: All EPS numbers presented in this write-up represent funds from operations (“FFO”) per share. FFO, a widely used metric to gauge the performance of REITs, is obtained after adding depreciation and amortization and other non-cash expenses to net income.

Confidential from Zacks

Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>



ARBOR RLTY TRST (ABR): Free Stock Analysis Report

VENTAS INC (VTR): Free Stock Analysis Report

ALEXANDRIA REAL (ARE): Free Stock Analysis Report

CARETRUST REIT (CTRE): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.